Intrastromal Corneal Ring for High Astigmatism on Postkeratoplasty

Status Completed

Clinical Trial Summary

To evaluate the clinical outcomes of Intrastromal Corneal Ring Segment (ICRS) implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (PK).

Clinical Trial Description

Eighteen eyes of 18 patients, 8 men and 10 women, with high levels (> 5 diopters [D]) of postkeratoplasty astigmatism were studied in a nonrandomized, retrospective, observational case series. Mean age at the time of ICRS implantation was 38 years, range 22 to 49 years. PK was performed to treat keratoconus in 15 patients, corneal scar after trauma in 2 patients, and Fuchs endothelial dystrophy in 1 patient. All patients were spectacle and contact lens intolerant. There was no active corneal disease or problem apart from high astigmatism.

Minimum time of ICRS implantation was 2 years after PK and at least 6 months after sutures removal.

Preoperative examinations included personal medical ocular history, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refraction, keratometry, intraocular pressure (IOP) measurement by applanation tonometry, corneal astigmatism, surface regularity index, surface asymmetry index, tonometry, slit-lamp biomicroscopy, specular microscopy, and fundus examination.

Main outcome measures included UCVA, BSCVA, refraction, keratometry and computerized analysis of corneal topography.

All surgeries were performed by the same surgeon (BAN) at the Goiania Eye Institute, between July 2007 and January 2009. Corneal tunnels were created by means of mechanical dissection in all eyes. Intrastromal corneal ring segments implantation was indicated because of the existence of reduced best spectacle-corrected visual acuity (BSCVA) or contact lens intolerance. Intracorneal ring segments implantations were performed by the same surgeon following the same protocol. All eyes were implanted with the Cornealring (Visiontech Medical Optics, Belo Horizonte, MG, Brazil). Mean follow-up after ICRS implantation was 12 months (range, 09 to 22 months).

The procedure, its goals, and possible complications were explained and all patients signed an informed consent. The amount and axis of astigmatism to be corrected by ICRS was based on manifest refraction. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Astigmatism

Clinical Trial Details

NCT number	NCT01018797
Study type	Interventional
Source	Instituto de Olhos de Goiania
Contact
Status	Completed
Phase	Phase 4
Start date	January 2007
Completion date	November 2009

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04778501` - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia	N/A
Completed	`NCT04536571` - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses	N/A
Completed	`NCT05039112` - Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses	N/A
Completed	`NCT04613882` - Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses	N/A
Recruiting	`NCT05611294` - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction	N/A
Completed	`NCT05633082` - A Clinical Performance of Two Soft Toric Contact Lenses	N/A
Not yet recruiting	`NCT05506553` - Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision	N/A
Not yet recruiting	`NCT05561296` - Astigmatism Management With Iris-registration Guided Corneal Relaxing Incisions or Toric IOLs During Cataract Surgery	N/A
Completed	`NCT02847169` - Clinical Performance of Toric Hydrogel Contact Lenses Following One Week of Daily Wear	N/A
Recruiting	`NCT02618018` - Clinical Evaluation of Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery	N/A
Completed	`NCT02423109` - Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses	N/A
Completed	`NCT02555098` - A Bilateral Dispensing Clinical Trial of an Sapphire Lens Against Senofilcon A Toric for Astigmatism Lens	N/A
Completed	`NCT02550353` - Changes Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis	N/A
Completed	`NCT02551796` - Early Changes Among FLEx, LASIK and FS-LASIK	N/A
Completed	`NCT02248766` - Clinical Performance of Habitual Wearers of Avaira Toric When Refitted With Clariti Toric Lenses	N/A
Completed	`NCT01857102` - Toric Eye Strain and Stability Study	N/A
Completed	`NCT01965288` - Clinical Performance of Biofinity Toric Versus Air Optix for Astigmatism	N/A
Withdrawn	`NCT01680354` - Surgical Correction of Astigmatism	N/A
Completed	`NCT02624791` - Evaluating and Improving Functional Driving Vision of Patients With Astigmatism	N/A
Completed	`NCT01207466` - Evaluation of Two Daily Disposable Contact Lenses for Wearers With Astigmatism	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intrastromal Corneal Ring for High Astigmatism on Postkeratoplasty — Anel

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms